These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 19852727)
1. Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Wendt MK; Allington TM; Schiemann WP Future Oncol; 2009 Oct; 5(8):1145-68. PubMed ID: 19852727 [TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. Taylor MA; Parvani JG; Schiemann WP J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795 [TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition in hepatocellular carcinoma. van Zijl F; Zulehner G; Petz M; Schneller D; Kornauth C; Hau M; Machat G; Grubinger M; Huber H; Mikulits W Future Oncol; 2009 Oct; 5(8):1169-79. PubMed ID: 19852728 [TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition in development and cancer. Micalizzi DS; Ford HL Future Oncol; 2009 Oct; 5(8):1129-43. PubMed ID: 19852726 [TBL] [Abstract][Full Text] [Related]
5. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838 [TBL] [Abstract][Full Text] [Related]
6. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Rajasekaran SA; Huynh TP; Wolle DG; Espineda CE; Inge LJ; Skay A; Lassman C; Nicholas SB; Harper JF; Reeves AE; Ahmed MM; Leatherman JM; Mullin JM; Rajasekaran AK Mol Cancer Ther; 2010 Jun; 9(6):1515-24. PubMed ID: 20501797 [TBL] [Abstract][Full Text] [Related]
7. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Wendt MK; Tian M; Schiemann WP Cell Tissue Res; 2012 Jan; 347(1):85-101. PubMed ID: 21691718 [TBL] [Abstract][Full Text] [Related]
8. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Katsuno Y; Lamouille S; Derynck R Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193 [TBL] [Abstract][Full Text] [Related]
9. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Galliher AJ; Schiemann WP Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511 [TBL] [Abstract][Full Text] [Related]
10. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies. Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Miyazono K Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(8):314-23. PubMed ID: 19838011 [TBL] [Abstract][Full Text] [Related]
12. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546 [TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes. Räsänen K; Vaheri A J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617 [TBL] [Abstract][Full Text] [Related]
14. The relevance of the TGF-β Paradox to EMT-MET programs. Morrison CD; Parvani JG; Schiemann WP Cancer Lett; 2013 Nov; 341(1):30-40. PubMed ID: 23474494 [TBL] [Abstract][Full Text] [Related]
15. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Neil JR; Johnson KM; Nemenoff RA; Schiemann WP Carcinogenesis; 2008 Nov; 29(11):2227-35. PubMed ID: 18725385 [TBL] [Abstract][Full Text] [Related]
16. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Sokol JP; Neil JR; Schiemann BJ; Schiemann WP Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131 [TBL] [Abstract][Full Text] [Related]
17. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885 [TBL] [Abstract][Full Text] [Related]